Noubar Afeyan
Co-Founder; Managing Partner, Flagship Ventures

Noubar Afeyan is a Co-Founder of LS9 and Managing Partner of Flagship Ventures. He is a technologist, entrepreneur and venture capitalist. He has founded and helped build 15 successful life science and technology startups during the past two decades. In addition, he is a Senior Lecturer at MIT in both the Sloan School of Management and the Biological Engineering Department. Noubar has authored numerous scientific publications as well as patents, and earned his Ph.D. in Biochemical Engineering from MIT in 1987 where he worked on the microbial conversion of cellulosic biomass into ethanol.

In 1999 Noubar co-founded Flagship Ventures, an early stage venture capital and entrepreneurship firm. Prior to that, he participated in creating and launching six highly successful new ventures. He was the Founder, Chairman, and CEO of PerSeptive Biosystems (NASDAQ: PBIO), a leader in the bio-instrumentation field. He also served as Chairman of the Board of ChemGenics Pharmaceuticals, a pioneer in genomics-based drug discovery that was a spin-off company of PerSeptive. After PerSeptive's acquisition by Applera Corporation (NYSE: ABI), he was Senior Vice President and Chief Business Officer of Applera, where he initiated and oversaw the creation of their tracking stock subsidiary, Celera Genomics (NYSE: CRA). He has also been a founding team member, investor and active board member/advisor of Antigenics (NASDAQ: AGEN), Color Kinetics (NASDAQ: CLRK) and EXACT Sciences (NASDAQ: EXAS).

In addition to being a Co-Founder and Director of LS9, Noubar currently serves as a Director for the following Flagship portfolio companies in which he is part of the founding team: Adnexus Therapeutics, Affinnova, BG Medicine, Codon Devices, Ensemble Discovery, Genstruct, Helicos BioSciences (NASDAQ:HLCS), T2 Biosystems. He is also engaged as an advisor with Flagship portfolio companies BIND Biosciences, Epitome Biosystems, and Mascoma. In addition, he is a member of the Boston University Board of Overseers and a member of several advisory boards including the Whitehead Institute at MIT, the Harvard-MIT Division of Health Sciences and Technology (HST), the Boston University Medical School and the Skolkovo School of Management in Moscow. He is also a founder/board member of Armenia 2020, an international economic development project focusing on the former Soviet Republic of Armenia.

Bill Haywood
Chief Executive Officer

Bill Haywood is Chief Executive Officer of LS9. He brings over 30 years of fuel manufacturing, refining, and marketing experience to the company. Most recently, he was the SVP of Manufacturing for Tesoro Petroleum, where he was responsible for the company's seven refineries and over $20 billion in revenue. Under his leadership, Tesoro became a leading independent refiner by integrating refinery acquisitions, driving operational excellence, and building over $1 billion in capital projects. During this period, shareholder value increased by more than 86% and earnings per share increased almost fivefold - resulting in recognition by the Wall Street Journal as a top oil and gas performance leader and a number one ranking by Forbes Magazine in the oil and gas category for the 400 Best Big Companies of 2008. Mr. Haywood has a strong track record of environmental stewardship and bringing clean fuels to market in partnership with regulatory agencies such as the California Air Resources Board (CARB), Bay Area Air Quality Management District and South Coast Air Quality Management District. His leadership approach centers on alignment around common goals and helping team members exceed their own expectations. He is a pragmatist who is known for balancing vision with risk, finance with safety, and people with processes. Previously, Mr. Haywood served as Regional Vice President of Ultramar Diamond Shamrock Corporation, where he was responsible for the company's California refineries. He has also served on the Board of Directors of the Northern California Special Olympics, Texas Special Olympics and the Boys and Girls Club of Long Beach, California.

Mr. Haywood received a B.S. degree in Biology from Miami University (Ohio), a B.S. degree in Civil Engineering from Ohio State University, and an MBA from Pepperdine University.

Peter Nieh
Managing Director, Lightspeed Venture Partners

Peter Nieh is a founding partner of Lightspeed Venture Partners, covering the areas of cleantech, software, and the internet. He has twelve years of venture capital experience and seven years of operating experience. Mr. Nieh has led Lightspeed's investments in energy related companies such as Coaltek, Stion and Mobius Power, and software/internet companies such as Blue Nile, Doubleclick, Informatica, and Phone.com (Openwave).

Prior to Lightspeed, Mr. Nieh worked in business development and product marketing at General Magic, a startup which before the emergence of the Web pioneered the development of e-commerce and electronic media services by partnering with the world's largest telecommunications service providers and consumer electronics companies. He also managed Acer's portable PC business in North America, where he launched the company's first laptop and notebook PCs. Before Acer, Mr. Nieh was a strategy consultant at Bain & Company where he worked predominately with high-technology clients on product and sales & distribution strategies. While an undergraduate at Stanford, he worked at Apple Computer where he helped to develop the power management system for Apple's first portable computer.

Mr. Nieh holds a BS in Electrical Engineering, an AB in Economics, and an MBA from Stanford University.

Charles L. Cooney
Massachusetts Institute of Technology

Charles L. Cooney is Robert T. Haslam (1911) Professor of Chemical Engineering at the Massachusetts Institute of Technology. He is the Faculty Director of the Deshpande Center for Technological Innovation, Co-Director of the Program on the Pharmaceutical Industry (POPI) and MIT faculty director of the Consortium on Advanced Manufacturing for Pharmaceuticals (CAMP). He serves as a consultant to a number of biotech and pharmaceutical companies, is on several editorial boards of professional journals, sits on the Boards of Directors of Genzyme, BioProcessors and Biocon, Ltd (India), and was a member of the BP Technical Advisory Council from 2001-2007. He chaired the FDA Advisory Committee for Pharmaceutical Science from 2004-2006.

Dr. Cooney's research interests span a range of topics in biochemical engineering and manufacturing strategy in the pharmaceutical, biotech and biofuels industries, as well as bioprocess design, operation and control. He has published over 300 research papers, over 30 patents and co-authored or edited 5 books including the recently published Development of Sustainable Bioprocesses: Modeling and Assessment, Wiley Press 2006. As founding faculty director of the Deshpande Center, he is interested in the process of stimulating technological innovation and translating innovation into new company creation.

Dr. Cooney received his Bachelor's degree in Chemical Engineering from the University of Pennsylvania in 1966. His Master's and Ph.D. degrees in Biochemical Engineering are from MIT in 1967, and 1970, respectively. After a short post-doctoral time at the Squibb Institute for Medical Research in 1970, he joined the MIT faculty as an Assistant Professor in 1970 and became a full Professor in 1982. He received the 1989 Gold Medal of the Institute of Biotechnological Studies (London), the Food, Pharmaceutical and Bioengineering Award from the American Institute of Chemical Engineers and the James Van Lanen Distinguished Service Award from the American Chemical Society's Division of Microbial and Biochemical Technology and was elected to the American Institute of Medical and Biochemical Engineers.

Christopher Stone
Advisor to the Board

Christopher Stone is an advisor to the Board and has over 17 years of legal and intellectual property experience, including 12 years of experience in industrial biotechnology. Mr. Stone has previously held the roles of Vice President, Intellectual Assets at Danisco A/S and Vice President, General Patent Counsel at Genencor International, Inc. Mr. Stone's responsibilities have included intellectual property protection and management, contract negotiation and drafting, participation in business operations and strategic planning, and litigation management.

Mr. Stone received his J.D. from the George Washington University, National Law Center and a B.S., Biochemistry, from the University of Massachusetts.